Design Therapeutics Statistics
NASDAQ: DSGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
9.02-0.30 (-3.22%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Design Therapeutics by the numbers
Design Therapeutics has a market capitalization of $577.6 million based on 64.04M shares outstanding. With trailing EPS of $-1.20, Design Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.0% below its 50-day average and 25.9% below its 200-day average.
Average daily trading volume is 554.69K shares, or about $5.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DSGN valuation vs. peer median
| Metric | DSGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $577.61M | $555.46M | +4% |
| Avg. volume | 554.69K | 1.41M | -61% |
Peer median across 8 companies: IMMX, ANNX, GERN, BCAX, ANL, ACRS, AVBP, CBIO.
Valuation
- Market cap
- $577.61M
- EPS (TTM)
- $-1.20
- Shares outstanding
- 64.04M
Price and trading
- Previous close
- 9.32
- Open
- 9.18
- Day range
- 8.97 – 9.57
- 52-week range
- 8.21 – 17.25
- 52-week change
- +8.02%
- Beta
- —
- Volume
- 281.93K
- Average volume
- 554.69K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 577.61M
- Forward Pe
- -5.81
- Eps
- -1.20
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.25
- Week52 Low
- 8.21
- Avg Volume
- 554.69K
- Shares Outstanding
- 64.04M
- Ma50
- 11.14
- Ma200
- 12.17
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -47.71%
- Pct From52w Low
- 9.87%